Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Companion Spine France

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Companion Spine France

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Companion Spine France. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from May 22, 2026 to May 22, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code NQO appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P110008, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: Immeuble Le Bridge - 5 Allee Des Acacias, Merignac Gironde, 33700. Recorded on P110008/S015, decision dated May 22, 2026.

Changes described in PMA records

P110008/S015: coflex Interlaminar Technology

FDA’s recorded scope: The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) supplement, which requested termination of study enrollment and subject follow-up for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P110008. Based upon the information submitted, the PMA supplement is approved.

May 22, 2026 · Normal 180 Day Track No User Fee

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Companion Spine FrancePMA supplementMay 22, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.